Successful Immunomodulatory Therapy in Castleman Disease with Paraneoplastic Pemphigus Vulgaris

被引:31
作者
Miltenyi, Zsofia [1 ]
Toth, Judit [2 ]
Gonda, Andrea [2 ]
Tar, Ildiko [3 ]
Remenyik, Eva [4 ]
Illes, Arpad [1 ]
机构
[1] Univ Debrecen, Dept Internal Med 3, Med & Hlth Sci Ctr, H-4012 Debrecen, Hungary
[2] Univ Debrecen, Dept Oncol, Med & Hlth Sci Ctr, H-4012 Debrecen, Hungary
[3] Univ Debrecen, Dept Parodontol, Med & Hlth Sci Ctr, H-4012 Debrecen, Hungary
[4] Univ Debrecen, Dept Dermatol, Med & Hlth Sci Ctr, H-4012 Debrecen, Hungary
关键词
Castleman disease; Immunmodulatory; PET/CT; VIRAL LOAD; PATIENT;
D O I
10.1007/s12253-008-9133-x
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Castleman disease is a rare lymphoproliferative disorder. The clinical signs and symptoms of the disease are primarily mediated by cytokines, especially interleukin-6. We presented the case of a young female. In May 2004, a 30-year-old otherwise healthy looking woman presented with oral ulcerations resistant to topical and systemic antibiotic and antimycotic treatment. Bullous mucosal lichen or pemphigus vulgaris were suspected. Histological examination and direct and indirect immunofluorescence confirmed the diagnosis of pemphigus. Search for neoplasm revealed a retroperitoneal Castleman tumour sized 15 x 6 x 5 cm in the abdominal MRI. The tumour was a bleeder, so the removal was partial. Histological examination showed hyalin hypervascular Castleman disease. Considering her young, fertile age and the multicentric Castleman disease,
引用
收藏
页码:375 / 381
页数:7
相关论文
共 18 条
[1]   Paraneoplastic pemphigus [J].
Anhalt, GJ .
JOURNAL OF INVESTIGATIVE DERMATOLOGY SYMPOSIUM PROCEEDINGS, 2004, 9 (01) :29-33
[2]   PARANEOPLASTIC PEMPHIGUS - AN AUTOIMMUNE MUCOCUTANEOUS DISEASE ASSOCIATED WITH NEOPLASIA [J].
ANHALT, GJ ;
KIM, S ;
STANLEY, JR ;
KORMAN, NJ ;
JABS, DA ;
KORY, M ;
IZUMI, H ;
RATRIE, H ;
MUTASIM, D ;
ARISSABDO, L ;
LABIB, RS .
NEW ENGLAND JOURNAL OF MEDICINE, 1990, 323 (25) :1729-1735
[3]  
[Anonymous], 1954, N Engl J Med, V250, P26
[4]   The aetiology and management of Castleman disease at 50 years: translating pathophysiology to patient care [J].
Casper, C .
BRITISH JOURNAL OF HAEMATOLOGY, 2005, 129 (01) :3-17
[5]   Paraneoplastic pemphigus associated with Castleman tumor, myasthenia gravis, and bronchiolitis obliterans [J].
Chorzelski, T ;
Hashimoto, T ;
Maciejewska, B ;
Amagai, M ;
Anhalt, GJ ;
Jablonska, S .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1999, 41 (03) :393-400
[6]   Pemphigus vulgaris with involvement of the cervix treated using thalidomide therapy [J].
Cunha, PR ;
de Oliveira, JR ;
Salles, MJ ;
Jamora, J ;
Bystryn, JC .
INTERNATIONAL JOURNAL OF DERMATOLOGY, 2004, 43 (09) :682-684
[7]   Castleman disease [J].
Dham, Anu ;
Peterson, Bruce A. .
CURRENT OPINION IN HEMATOLOGY, 2007, 14 (04) :354-359
[8]   Multicentric Castleman disease: Use of HHV8 viral load monitoring and positron emission tomography during follow-up [J].
Dieval, C. ;
Bonnet, F. ;
Mauclere, S. ;
Masquelier, B. ;
Bentaberry, F. ;
Cazeau, Al ;
Morlat, P. .
LEUKEMIA & LYMPHOMA, 2007, 48 (09) :1881-1883
[9]  
Harris NL, 2008, ANN ONCOL, V19, P119
[10]   Effects of bortezomib on pro-inflammatory cytokine levels and transfusion dependency in a patient with multicentric Castleman Disease [J].
Hess, Georg ;
Wagner, Volker ;
Kreft, Andreas ;
Heussel, Claus Peter ;
Huber, Christoph .
BRITISH JOURNAL OF HAEMATOLOGY, 2006, 134 (05) :544-545